<DOC>
	<DOCNO>NCT01704027</DOCNO>
	<brief_summary>The purpose study evaluate incidence urinary rectal acute side effect pelvic prostatic intensity-modulated arctherapy simultaneous integrate boost ( SIB-IMRT ) combine long-term androgen deprivation patient high risk localize prostate cancer</brief_summary>
	<brief_title>Safety Study Pelvic Prostatic SIB-IMRT With Long-term Androgen Deprivation High Risk Localized Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>1 . Histologically confirm adenocarcinoma prostate 2 . High risk localize adenocarcinoma define least one follow criterion : Clinical stage T2c , T3 T4 Gleason score ≥ 8 Prostatespecific antigen ( PSA ) ≥ 20 ng/ml ≤ 100 ng/ml 3 . Patient cN0 , pN0 Nx ( negative lymphadenectomy lymphadenectomy ) 4 . No pelvic adenopathy ≥ 15 mm CT MRI , 5 . Absence bone and/or visceral metastasis 6 . Androgen deprivation begin later day radiotherapy six month irradiation 7 . Absence prior pelvic radiotherapy , 8 . Absence surgical treatment prostate cancer except transurethral resection perform within 4 month minimum radiotherapy , 9 . Age ≥ 18 year ≤ 85 year 10 . ECOG performance status ≤ 1 , 11 . Estimated life expectancy &gt; 5 year 12 . Membership social security system , 13 . Signed informed consent . 1 . Prostate cancer histology adenocarcinoma , 2. pN1 patient ( lymph node dissection histologically proven ) 3 . PSA &gt; 100 ng/ml 4 . History cancer within 5 year prior trial entry ( exception basal cell carcinoma skin ) 5 . Patient severe hypertension uncontrolled appropriate treatment ( ≥ 160 mm Hg systolic / ≥ 90 mm Hg diastolic ) 6 . Contraindication pelvic irradiation ( eg scleroderma , chronic inflammatory disease digestive tract , etc ... ) 7 . Contraindication agonists antagonist LHRH 8 . Bilateral hip prosthesis , 9 . Patients already include another clinical trial experimental molecule , 10 . Persons deprive liberty guardianship 11 . Unable undergo medical test geographical , social psychological .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Localized</keyword>
	<keyword>High risk</keyword>
</DOC>